Brief: Quince Announces Acquisition Of Orphai And Up To $187 Million Private Placement To Advance Pulmonary Pipeline
18/05/2026 14:50
May 18 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE ANNOUNCES ACQUISITION OF ORPHAI AND UP TO $187 MILLION PRIVATE PLACEMENT TO ADVANCE PULMONARY PIPELINE Source text: ID:nGNX3nCqSF Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges